"Nitroimidazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
IMIDAZOLES having a nitro moiety.
| Descriptor ID |
D009593
|
| MeSH Number(s) |
D02.640.672 D03.383.129.308.658
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitroimidazoles".
Below are MeSH descriptors whose meaning is more specific than "Nitroimidazoles".
This graph shows the total number of publications written about "Nitroimidazoles" by people in this website by year, and whether "Nitroimidazoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitroimidazoles" by people in Profiles.
-
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial. J Geriatr Oncol. 2020 04; 11(3):463-469.
-
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2017 08; 18(8):1089-1103.